Core Viewpoint - A class action lawsuit has been filed against Skye Bioscience, Inc. for alleged violations of the Securities Exchange Act, specifically related to misleading statements about the efficacy of its drug nimacimab [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from November 4, 2024, to October 3, 2025, with a deadline for lead plaintiff appointments set for January 16, 2026 [2]. - The complaint alleges that Skye made false and misleading statements regarding the efficacy of nimacimab, which did not demonstrate the claimed effectiveness [2]. Group 2: Shareholder Participation - Shareholders who purchased shares during the class period are encouraged to contact the DJS Law Group for potential lead plaintiff appointments, although this is not required to participate in any recovery [2][3]. - Once registered, shareholders will be enrolled in a portfolio monitoring system to receive updates on the case's progress at no cost [3]. Group 3: DJS Law Group's Role - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4]. - The firm represents large hedge funds and alternative asset managers, emphasizing the value of litigation claims as significant assets [4].

Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. for alleged violations of securities laws, specifically for making false and misleading statements regarding enrollment figures and compliance practices [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from October 22, 2024, to October 28, 2025, with a deadline for lead plaintiff appointments set for January 12, 2026 [2]. - The complaint alleges that Stride misrepresented enrollment figures by including "ghost students" and failed to conduct necessary background checks and compliance requirements, leading to materially misleading public statements [2]. Group 2: Shareholder Participation - Shareholders who purchased shares during the specified class period are encouraged to contact the law firm for potential participation in the lawsuit, with no cost or obligation to join [3]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's progress [3]. Group 3: Law Firm Background - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy [4]. - The firm represents large hedge funds and alternative asset managers, emphasizing the value of litigation claims as significant assets [4].

Core Viewpoint - A class action lawsuit has been filed against Alexandria Real Estate Equities, Inc. for alleged violations of securities laws, specifically for making false and misleading statements regarding its development tenant pipeline [1][2]. Group 1: Lawsuit Details - The class period for the lawsuit is from January 27, 2025, to October 27, 2025, with a deadline for lead plaintiff appointments set for January 26, 2026 [2]. - The complaint alleges that Alexandria made false claims about its positive comments on its development tenant pipeline, which were not based on factual information, rendering its public statements materially misleading [2]. Group 2: Shareholder Participation - Shareholders who purchased shares during the class period are encouraged to contact the DJS Law Group for potential lead plaintiff appointments, although this is not a requirement for recovery [2][3]. - Once registered, shareholders will be enrolled in a portfolio monitoring software to receive updates on the case's status, with no cost or obligation to participate [3]. Group 3: DJS Law Group Overview - DJS Law Group specializes in securities class actions, corporate governance litigation, and M&A appraisals, focusing on enhancing investor returns through advocacy [4]. - The firm represents some of the largest hedge funds and alternative asset managers, emphasizing the value of litigation claims as significant assets [4].

Core Viewpoint - Firefly Aerospace Inc. is facing a class action lawsuit for alleged violations of federal securities laws, with claims that the company made false and misleading statements regarding its business operations and the demand for its products [1][3]. Summary by Sections Class Action Details - The class period for the lawsuit is defined as from August 7, 2025, to September 29, 2025, during which shareholders are encouraged to contact the DJS Law Group for potential lead plaintiff appointments [2]. - The lawsuit alleges that Firefly exaggerated the demand for its Spacecraft Solutions division and misled investors about the commercial potential of the Alpha rocket, resulting in materially misleading public statements throughout the class period [3]. Next Steps for Shareholders - Shareholders who purchased shares of Firefly during the specified timeframe can register to participate in the case, which includes enrollment in a portfolio monitoring software for status updates [4]. Legal Representation - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy and legal support [5].

Core Viewpoint - Skye Bioscience, Inc. is facing a class action lawsuit for securities law violations, specifically for making false and misleading statements regarding the efficacy of its product, nimacimab [1][2]. Summary by Sections Class Action Details - The class period for the lawsuit is from November 4, 2024, to October 3, 2025, with a deadline for lead plaintiff appointments set for January 16, 2026 [2]. - The complaint alleges that Skye's public statements were materially misleading, as the company failed to demonstrate the efficacy of nimacimab as previously claimed [2]. Shareholder Participation - Shareholders who purchased shares during the specified class period are encouraged to contact the DJS Law Group to participate in the lawsuit [3]. - There is no cost or obligation for shareholders to enroll in the case, and they will receive updates through a portfolio monitoring software [3]. Legal Representation - DJS Law Group specializes in securities class actions and corporate governance litigation, representing large hedge funds and alternative asset managers [4].

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of James Hardie Industries plc regarding a class action lawsuit due to alleged false statements and concealment of adverse facts related to the company's North America segment [1][3]. Summary by Sections Class Action Details - The class period for the lawsuit is from May 20, 2025, to August 18, 2025 [3]. - Allegations include that James Hardie's North America segment experienced deteriorating consumer demand and that growth was primarily driven by overstocking rather than actual consumer demand, leading to excessive inventory at distributors [3]. Shareholder Information - Shareholders are encouraged to register for the class action by December 23, 2025, to potentially be appointed as lead plaintiffs [4]. - Registration allows shareholders to receive updates on the case through portfolio monitoring software [4]. Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies engage in responsible business practices and seeks recovery for investors who suffered losses due to misleading statements or omissions [5].

Core Insights - Ardent Health, Inc. is under investigation by Levi & Korsinsky for potential violations of federal securities laws [1] - The company reported a $43 million reduction in revenue and a $54 million increase in professional liability reserves in its Q3 2025 financial results [2] - Following the financial disclosures, Ardent's stock experienced a significant decline during pre-market trading [3] Financial Performance - Ardent Health disclosed a $43 million decrease in revenue due to changes in accounting estimates regarding accounts receivable [2] - The company also announced a $54 million increase in professional liability reserves related to claims in New Mexico [2] Market Reaction - The stock price of Ardent Health fell significantly in pre-market trading on November 13, 2025, following the release of its financial results [3]

Core Insights - Bitdeer Technologies Group is under investigation for possible violations of federal securities laws by Levi & Korsinsky [1] - The company reported a significant earnings miss for Q3 2025, with an earnings per share of -$1.28 compared to the consensus estimate of -$0.22 [2] - Bitdeer announced delays in the development of its next-generation Seal 04 ASIC chip, which may impact future performance [2] - Following the earnings report and news of the delays, Bitdeer's stock price dropped over 14% on November 11, 2025 [2] Company Performance - Bitdeer reported unaudited financial results for Q3 2025, highlighting a substantial loss in earnings per share [2] - The company faced significant operational challenges, particularly with the delay in the development of its ASIC chip [2] Market Reaction - The stock price of Bitdeer fell by more than 14% in response to the negative earnings report and the announcement of delays [2]

Core Insights - Fiserv, Inc. is a global provider of financial services technology, offering services such as payment processing, risk management, and data analytics, and is set to go public on NASDAQ [1] - The Schall Law Firm is investigating Fiserv for potential securities law violations related to misleading statements and undisclosed information following a disappointing third-quarter earnings report [2][6] - Fiserv's CEO acknowledged that previous forecasts were overly optimistic, leading to a 43% drop in stock price on the day of the earnings report [3][6] Financial Performance - Fiserv's stock is currently priced at $114.23, with fluctuations between a low of $112.54 and a high of $114.23 on the day [4] - Over the past year, the stock has reached a high of $188.85 and a low of $109.115, with a market capitalization of approximately $116.2 billion [4] - Today's trading volume for FISV is 20,051,164 shares, indicating significant investor interest amid ongoing challenges [5][6]

Company Overview - Beyond Meat, Inc. specializes in plant-based meat alternatives, including products like the Beyond Burger, and utilizes non-GMO ingredients [3]. Allegations and Financial Impact - On October 24, 2025, Beyond Meat announced a significant non-cash impairment charge on certain assets, which led to a stock price drop of over 23% [4]. - Following the announcement, the company delayed its third-quarter earnings release on November 3, 2025, resulting in an additional decline of 16.52% in its share price [4]. Legal Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws related to Beyond Meat, stemming from allegations of providing misleading business information to investors [1].